{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:00:41Z","timestamp":1792641641640,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Current Research Funds"],"award-info":[{"award-number":["Current Research Funds"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s40272-024-00679-x","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T12:49:20Z","timestamp":1736772560000},"page":"293-305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Off-Label Use of Anakinra in Inflammatory Conditions in Neonates and Infants Up to 3 Months of Age: A Case Series and a Review of the Literature"],"prefix":"10.1007","volume":"27","author":[{"given":"Domenico Umberto","family":"De Rose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Campi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Maddaloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9559-1631","authenticated-orcid":false,"given":"Sara","family":"Ronci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Caoci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immacolata","family":"Savarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iliana","family":"Bersani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paola","family":"Ronchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Auriti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Capolupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Merli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Insalaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"De Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Dotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"issue":"10","key":"679_CR1","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1001\/jama.291.10.1203","volume":"291","author":"RH Pantell","year":"2004","unstructured":"Pantell RH, Newman TB, Bernzweig J, Bergman DA, Takayama JI, Segal M, et al. Management and outcomes of care of fever in early infancy. JAMA. 2004;291(10):1203\u201312.","journal-title":"JAMA"},{"issue":"10104","key":"679_CR2","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/S0140-6736(17)31002-4","volume":"390","author":"AL Shane","year":"2017","unstructured":"Shane AL, S\u00e1nchez PJ, Stoll BJ. Neonatal sepsis. Lancet. 2017;390(10104):1770\u201380.","journal-title":"Lancet"},{"issue":"3","key":"679_CR3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41372-020-0744-8","volume":"41","author":"DU De Rose","year":"2021","unstructured":"De Rose DU, Coppola M, Gallini F, Maggio L, Vento G, Rigante D. Overview of the rarest causes of fever in newborns: handy hints for the neonatologist. J Perinatol. 2021;41(3):372\u201382.","journal-title":"J Perinatol"},{"issue":"8","key":"679_CR4","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrd3800","volume":"11","author":"CA Dinarello","year":"2012","unstructured":"Dinarello CA, Simon A, Van Der Meer JWM. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov. 2012;11(8):633\u201352.","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"679_CR5","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1007\/s10067-018-4119-x","volume":"37","author":"J Sota","year":"2018","unstructured":"Sota J, Vitale A, Insalaco A, Sfriso P, Lopalco G, Emmi G, et al. Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study. Clin Rheumatol. 2018;37(8):2233\u201340.","journal-title":"Clin Rheumatol"},{"key":"679_CR6","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/S0140-6736(04)17401-1","volume":"364","author":"HM Hoffman","year":"2004","unstructured":"Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL, et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet. 2004;364:1779\u201385.","journal-title":"Lancet"},{"issue":"23","key":"679_CR7","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1056\/NEJMoa0809568","volume":"360","author":"S Reddy","year":"2009","unstructured":"Reddy S, Jia S, Geoffrey R, Lorier R, Suchi M, Broeckel U, et al. An autoinflammatory disease due to homozygous deletion of the IL1RN locus. N Engl J Med. 2009;360(23):2438\u201344.","journal-title":"N Engl J Med"},{"issue":"1","key":"679_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12969-016-0081-9","volume":"14","author":"S Peciuliene","year":"2016","unstructured":"Peciuliene S, Burnyte B, Gudaitiene R, Rusoniene S, Drazdiene N, Liubsys A, et al. Perinatal manifestation of mevalonate kinase deficiency and efficacy of anakinra. Pediatr Rheumatol. 2016;14(1):16\u20139.","journal-title":"Pediatr Rheumatol"},{"key":"679_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1759720X20959575","volume":"12","author":"V Maniscalco","year":"2020","unstructured":"Maniscalco V, Abu-Rumeileh S, Mastrolia MV, Marrani E, Maccora I, Pagnini I, et al. The off-label use of anakinra in pediatric systemic autoinflammatory diseases. Ther Adv Musculoskelet Dis. 2020;12:1\u201319.","journal-title":"Ther Adv Musculoskelet Dis."},{"issue":"10","key":"679_CR10","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1136\/annrheumdis-2018-214472","volume":"78","author":"NM Ter Haar","year":"2019","unstructured":"Ter Haar NM, Eijkelboom C, Cantarini L, Papa R, Brogan PA, Kone-Paut I, et al. Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases. Ann Rheum Dis. 2019;78(10):1405\u201311.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"679_CR11","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S2665-9913(20)30096-5","volume":"2","author":"P Mehta","year":"2020","unstructured":"Mehta P, Cron RQ, Hartwell J, Manson JJ, Tattersall RS. Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome. Lancet Rheumatol. 2020;2(6):e358\u201367.","journal-title":"Lancet Rheumatol."},{"key":"679_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.942455","author":"\u015e \u00c7a\u01e7layan","year":"2022","unstructured":"\u00c7a\u01e7layan \u015e, S\u00f6nmez HE, Otar Yener G, Ba\u01e7lan E, \u00d6zt\u00fcrk K, Ulu K, et al. Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19. Front Pediatr. 2022. https:\/\/doi.org\/10.3389\/fped.2022.942455.","journal-title":"Front Pediatr"},{"key":"679_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1100551","author":"A Shrestha","year":"2023","unstructured":"Shrestha A, Wood EL, Berrios-Siervo G, Stredny CM, Boyer K, Vega C, et al. Long-term neuropsychological outcomes in children with febrile infection-related epilepsy syndrome (FIRES) treated with anakinra. Front Neurol. 2023. https:\/\/doi.org\/10.3389\/fneur.2023.1100551.","journal-title":"Front Neurol"},{"issue":"1","key":"679_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jitc-2021-003847","volume":"10","author":"M Wehrli","year":"2022","unstructured":"Wehrli M, Gallagher K, Chen Y-B, Leick MB, McAfee SL, El-Jawahri AR, et al. Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS). J Immunother Cancer. 2022;10(1):1\u20139.","journal-title":"J Immunother Cancer"},{"issue":"212","key":"679_CR15","first-page":"S18","volume":"36","author":"KO Zimmerman","year":"2019","unstructured":"Zimmerman KO, Benjamin DK, Becker ML. Neonatal therapeutics: considerations for dosing. Am J Perinatol. 2019;36(212):S18-21.","journal-title":"Am J Perinatol"},{"issue":"4","key":"679_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1586\/17476348.2014.909731","volume":"8","author":"B Girerd","year":"2014","unstructured":"Girerd B, Perros F, Antigny F, Humbert M, Montani D. KCNK3: new gene target for pulmonary hypertension? Expert Rev Respir Med. 2014;8(4):385\u20137.","journal-title":"Expert Rev Respir Med"},{"issue":"4","key":"679_CR17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jiph.2020.12.034","volume":"14","author":"M Alharbi","year":"2021","unstructured":"Alharbi M, Kazzaz YM, Hameed T, Alqanatish J, Alkhalaf H, Alsadoon A, et al. SARS-CoV-2 infection in children, clinical characteristics, diagnostic findings and therapeutic interventions at a tertiary care center in Riyadh, Saudi Arabia. J Infect Public Health. 2021;14(4):446\u201353.","journal-title":"J Infect Public Health"},{"issue":"SEP","key":"679_CR18","first-page":"1","volume":"9","author":"J Barsalou","year":"2018","unstructured":"Barsalou J, Blincoe A, Fernandez I, Dal-Soglio D, Marchitto L, Selleri S, et al. Rapamycin as an adjunctive therapy for NLRC4 associated macrophage activation syndrome. Front Immunol. 2018;9(SEP):1\u20136.","journal-title":"Front Immunol"},{"key":"679_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/children9050672","author":"G Bossi","year":"2022","unstructured":"Bossi G, Codazzi AC, Vinci F, Clerici E, Regalbuto C, Crapanzano C, et al. Efficacy of anakinra on multiple coronary arteries aneurysms in an infant with recurrent Kawasaki disease, complicated by macrophage activation syndrome. Children. 2022. https:\/\/doi.org\/10.3390\/children9050672.","journal-title":"Children"},{"issue":"12","key":"679_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pbc.27997","volume":"66","author":"SR Kim","year":"2019","unstructured":"Kim SR, Kissoon-Larkin T, Horn B, Elder M. Anakinra as an agent to control hemophagocytic lymphohistiocytosis in Griscelli type 2. Pediatr Blood Cancer. 2019;66(12):1\u20133.","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"679_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bcr-2019-229708","volume":"12","author":"M Lind-Holst","year":"2019","unstructured":"Lind-Holst M, Hartling UB, Christensen AE. High-dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant. BMJ Case Rep. 2019;12(8):1\u20134.","journal-title":"BMJ Case Rep"},{"issue":"July","key":"679_CR22","first-page":"1","volume":"9","author":"DJ McKeone","year":"2021","unstructured":"McKeone DJ, DeMartini TKM, Kavanagh RP, Halstead ES. Case report: rapid recognition and immune modulation of secondary HLH due to disseminated HSV infection. Front Pediatr. 2021;9(July):1\u20136.","journal-title":"Front Pediatr"},{"issue":"6","key":"679_CR23","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/jpids\/piaa137","volume":"9","author":"E Orlanski-Meyer","year":"2020","unstructured":"Orlanski-Meyer E, Yogev D, Auerbach A, Megged O, Glikman D, Hashkes PJ, et al. Multisystem Inflammatory syndrome in children associated with SARS-CoV-2 in an 8-week old infant. The journal of Pediatric Infectious Diseases Society. 2020;9(6):781\u20134.","journal-title":"The journal of Pediatric Infectious Diseases Society."},{"issue":"1","key":"679_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1546-0096-12-26","volume":"12","author":"A Shafferman","year":"2014","unstructured":"Shafferman A, Birmingham JD, Cron RQ. High dose anakinra for treatment of severe neonatal Kawasaki disease: a case report. Pediatr Rheumatol. 2014;12(1):1\u20135.","journal-title":"Pediatr Rheumatol"},{"issue":"July","key":"679_CR25","first-page":"1","volume":"9","author":"LA Shaiba","year":"2021","unstructured":"Shaiba LA, Altirkawi K, Hadid A, Alsubaie S, Alharbi O, Alkhalaf H, et al. COVID-19 disease in infants less than 90 days: case series. Front Pediatr. 2021;9(July):1\u20138.","journal-title":"Front Pediatr"},{"issue":"10","key":"679_CR26","doi-asserted-by":"publisher","first-page":"E310","DOI":"10.1097\/INF.0000000000002810","volume":"39","author":"M Walser","year":"2020","unstructured":"Walser M, Hermann M, Hufnagel M, Haas NA, Fischer M, Dalla-Pozza R, et al. Anakinra and etanercept combination treatment in a child with severe, nonresponsive Kawasaki disease. Pediatr Infect Dis J. 2020;39(10):E310\u20133.","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"679_CR27","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/art.41103","volume":"72","author":"EM Eloseily","year":"2020","unstructured":"Eloseily EM, Weiser P, Crayne CB, Haines H, Mannion ML, Stoll ML, et al. Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis. Arthritis Rheumatol. 2020;72(2):326\u201334.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"679_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","volume":"12","author":"AA Grom","year":"2016","unstructured":"Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol. 2016;12(5):259\u201368.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"679_CR29","first-page":"1","volume":"9","author":"DU De Rose","year":"2024","unstructured":"De Rose DU, Ronchetti MP, Santisi A, Bernaschi P, Martini L, Porzio O, et al. Stop in time: how to reduce unnecessary antibiotics in newborns with late-onset sepsis in neonatal intensive care. Trop Med Infect Dis. 2024;9(3):1\u201317.","journal-title":"Trop Med Infect Dis."},{"issue":"8","key":"679_CR30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour C, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA J Am Med Assoc. 2016;315(8):801\u201310.","journal-title":"JAMA J Am Med Assoc"},{"issue":"9","key":"679_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/tropicalmed9090199","volume":"9","author":"DU De Rose","year":"2024","unstructured":"De Rose DU, Ronchetti MP, Martini L, Rechichi J, Iannetta M, Dotta A, et al. Diagnosis and management of neonatal bacterial sepsis: current challenges and future perspectives. Trop Med Infect Dis. 2024;9(9):199.","journal-title":"Trop Med Infect Dis."},{"issue":"1","key":"679_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cmi.2023.02.021","volume":"30","author":"M Stocker","year":"2024","unstructured":"Stocker M, Giannoni E. Game changer or gimmick: inflammatory markers to guide antibiotic treatment decisions in neonatal early-onset sepsis. Clin Microbiol Infect. 2024;30(1):22\u20137.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"679_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v14040750","volume":"14","author":"DU De Rose","year":"2022","unstructured":"De Rose DU, Pugnaloni F, Cal\u00ec M, Ronci S, Caoci S, Maddaloni C, et al. Multisystem inflammatory syndrome in neonates born to mothers with SARS-CoV-2 infection (MIS-N) and in neonates and infants younger than 6 months with acquired COVID-19 (MIS-C): a systematic review. Viruses. 2022;14(4):1\u201331.","journal-title":"Viruses"},{"issue":"August","key":"679_CR34","first-page":"1","volume":"11","author":"F Licciardi","year":"2023","unstructured":"Licciardi F, Covizzi C, Dellepiane M, Olivini N, Mastrolia MV, Lo Vecchio A, et al. Outcomes of MIS-C patients treated with anakinra: a retrospective multicenter national study. Front Pediatr. 2023;11(August):1\u20136.","journal-title":"Front Pediatr"},{"issue":"6","key":"679_CR35","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s40272-020-00421-3","volume":"22","author":"G Ferrara","year":"2020","unstructured":"Ferrara G, Giani T, Caparello MC, Farella C, Gamalero L, Cimaz R. Anakinra for treatment-resistant Kawasaki disease: evidence from a literature review. Pediatr Drugs. 2020;22(6):645\u201352.","journal-title":"Pediatr Drugs"},{"issue":"2","key":"679_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/iid3.548","volume":"10","author":"P Engeroff","year":"2022","unstructured":"Engeroff P, Belb\u00e9zier A, Monsel A, Klatzmann D. Anakinra reduces lung inflammation in experimental acute lung injury. Immun Inflamm Dis. 2022;10(2):123\u20139.","journal-title":"Immun Inflamm Dis."},{"issue":"1","key":"679_CR37","doi-asserted-by":"publisher","first-page":"L49","DOI":"10.1152\/ajplung.00060.2019","volume":"317","author":"LC Eldredge","year":"2019","unstructured":"Eldredge LC, Creasy RS, Presneell S, Debley JS, Juul SE, Mayock DE, et al. Infants with evolving bronchopulmonary dysplasia demonstrate monocyte-specific expression of IL-1 in tracheal aspirates. Am J Physiol Lung Cell Mol Physiol. 2019;317(1):L49-56.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"679_CR38","first-page":"93","volume":"17","author":"L Cantarini","year":"2015","unstructured":"Cantarini L, Lopalco G, Cattalini M, Vitale A, Galeazzi M, Rigante D. Interleukin-1: Ariadne\u2019s thread in autoinflammatory and autoimmune disorders. Israel Med Assoc J. 2015;17(2):93\u20136.","journal-title":"Israel Med Assoc J"},{"issue":"13","key":"679_CR39","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00281-020-00803-2","volume":"42","author":"A Humberg","year":"2020","unstructured":"Humberg A, Fortmann I, Siller B, Kopp MV, Herting E, G\u00f6pel W, et al. Preterm birth and sustained inflammation: consequences for the neonate Network, German Center for Lung Research and Priming Immunity at the beginning of life (PRIMAL) Consortium. Semin Immunopathol. 2020;42(13):451\u201368.","journal-title":"Semin Immunopathol"},{"key":"679_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032795","author":"EA Green","year":"2023","unstructured":"Green EA, Garrick SP, Peterson B, Berger PJ, Galinsky R, Hunt RW, et al. The role of the Interleukin-1 family in complications of prematurity. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24032795.","journal-title":"Int J Mol Sci"},{"issue":"October","key":"679_CR41","first-page":"1","volume":"13","author":"EA Green","year":"2022","unstructured":"Green EA, Metz D, Galinsky R, Atkinson R, Skuza EM, Clark M, et al. Anakinra pilot\u2014a clinical trial to demonstrate safety, feasibility and pharmacokinetics of interleukin 1 receptor antagonist in preterm infants. Front Immunol. 2022;13(October):1\u201314.","journal-title":"Front Immunol"},{"issue":"2","key":"679_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105299","volume":"89","author":"G Lopalco","year":"2022","unstructured":"Lopalco G, Venerito V, Brucato A, Emmi G, Giacomelli R, Cauli A, et al. Anakinra effectiveness in refractory polyserositis: an Italian multicenter study. Jt Bone Spine. 2022;89(2): 105299.","journal-title":"Jt Bone Spine"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-024-00679-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-024-00679-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-024-00679-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T11:27:54Z","timestamp":1745580474000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-024-00679-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["679"],"URL":"https:\/\/doi.org\/10.1007\/s40272-024-00679-x","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]},"assertion":[{"value":"19 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by the Italian Ministry of Health with the Current Research funds.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study reported only a retrospective analysis of data available through the institutional database. Personal data were restricted to essential information and were treated in order to guarantee the respect of the privacy of the involved patient, as specifically stated by Italian Law D. Lgs n.196 of 2003 about personal data protection. Therefore, the study did not require preliminary evaluation by the local ethical committee. The Scientific Director of \u201cBambino Ges\u00f9\u201d Children\u2019s Hospital IRCCS approved the publication of this manuscript (request Ronci Sara-RAP-2024-0004, date of approval: 09\/07\/2024).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All parents signed a written informed consent form before their children were subjected to intensive care, with the possibility of data relating to hospitalization being obtained anonymously and reproduced.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All parents signed a written informed consent form before their children were subjected to intensive care, with the possibility of data relating to hospitalization being obtained anonymously and reproduced.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials (data transparency)"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability (software application or custom code)"}},{"value":"All authors were involved in writing the manuscript: DUDR designed the study, acquired and analyzed data from literature and patients\u2019 data, and drafted the initial manuscript; FC designed the study, acquired and analyzed data from literature and patients\u2019 data; CM, SR, SC, IS, IB, MPR and CA collected patients\u2019 data and revised the manuscript; IC, PM, FDB, and AI critically reviewed the manuscript for important intellectual content; AD supervised the study and critically reviewed the manuscript for important intellectual content. All authors approved the final manuscript as submitted and agreed to be accountable for all aspects of the work. All authors contributed to the article and approved the submitted version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}